SENATE-BILL 1587: S.1587 - Fair Prescription Drug Prices for Americans Act
AI-Powered Summary
SENATE-BILL 1587 aims to regulate the retail list prices of prescription drugs and biological products by capping prices based on international averages, with the overall purpose of lowering costs for individuals and enhancing access to necessary medications. The major themes addressed include healthcare affordability, regulation of pharmaceutical pricing, and the balance between consumer rights and manufacturers' economic liberties. Key provisions include the establishment of price caps, mandatory reporting of pricing data by manufacturers, and the imposition of civil monetary penalties for non-compliance. The Secretary of Health and Human Services is responsible for implementing regulations, which may introduce additional administrative scrutiny of drug pricing. Potential impacts include improved access to medications for consumers, but also concerns regarding the constitutional implications related to the Commerce Clause and the Takings Clause, as well as the risk of increased prices if manufacturers pass on compliance costs to consumers.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill has significant implications for individuals' access to healthcare, particularly for those in lower income brackets or with chronic health conditions. By capping drug prices, it seeks to ensure that all demographic groups can afford necessary medications, thereby promoting health equity.
Key Individual Rights
- Equal Protection under the law
- Access to healthcare
- Due Process rights concerning penalties
Constitutional Provisions
- Equal Protection Clause (14th Amendment)
- Commerce Clause (Article I, Section 8)
- Due Process Clause (14th Amendment)
Potential Constitutional Challenges Or Support
Support
The bill could be seen as a positive step toward reducing health disparities and ensuring equal access to essential medications for diverse demographic groups.
Concerns
- Regulatory overreach may infringe on manufacturers' rights to set prices.
- Potential negative impact on pharmaceutical innovation due to price caps.
- Due process issues related to penalties imposed on manufacturers.
Summary
SENATE-BILL 1587 aims to lower prescription drug prices, enhancing access to medications for individuals across various demographic groups. It promotes equal protection and health equity, particularly benefiting seniors, low-income individuals, and those with chronic conditions. However, it also raises concerns about regulatory overreach and potential impacts on innovation in the pharmaceutical industry.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention S. 1587 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
May 5, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat